The invention relates to a pharmaceutical
wastewater technology using microelectrolysis-Feton-EGSB (expanded granulate
sludge bed)-A / O (anaerobic / aerobic)-BCO (biological contact oxidization)-BAF (biological
aeration filtration)-coagulation treatment. High-concentration pharmaceutical
wastewater is sequentially sent into an
oil separation tank, a conditioning tank, a microelectrolysis reaction tank, a Feton
catalytic oxidation tower, a horizontal flow type primary
settling tank, a comprehensive conditioning tank, a
hydrolysis acidifying tank, the EGSB, an A / O tank, a two-stage BCO tank, a secondary
settling tank, a BAF tank, a coagulation tank, an air floating tank and a final
settling tank to be treated, and then is drained after the standard is reached. The technology has the advantages that the technique is matured, the
treatment effect is stable, and the anti-
impact ability is strong; after the pharmaceutical
wastewater is treated by the combined technology, the quality of drained water can reach the class-one standard of Comprehensive Drainage Standard of
Wastewater (GB8978-1996).